Find clinical trials for Triple Negative Breast Cancer in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Los Angeles, CA, USA:
(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...
Phase 1, Phase 2
Los Angeles, California, United States and 15 other locations
and pembrolizumab with LBP MO-03 in 50 trial participants with early triple negative breast cancer. MO-03 will be...
Phase 2
Beverly Hills, California, United States and 2 other locations
This is a single arm phase II trial combination of ivonescimab and carbo-docetaxel every 3 weeks for 6 cycles in patients with early-stage triple...
Phase 2
Los Angeles, California, United States and 3 other locations
to see how well they they work in shrinking tumors in patients with triple negative breast cancer that has spread...
Phase 1, Phase 2
Los Angeles, California, United States of America
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Santa Monica, California, United States and 23 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Los Angeles, California, United States and 216 other locations
This phase I trial tests the safety, side effects, and best dose of CF33-hNIS-antiPDL1 in treating patients with triple negative br ...
Phase 1
Duarte, California, United States
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Burbank, California, United States and 197 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Los Angeles, California, United States and 294 other locations
The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patie...
Phase 1
Los Angeles, California, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal